Kalvista Pharmaceuticals, Inc. · NASDAQ:KALV

Frazier Life Sciences Public Fund, L.P. reported a 6.90% stake in Kalvista Pharmaceuticals, Inc. (Schedule 13D/A)

Event Nov 1, 2025 · Filed Nov 4, 2025

Frazier Life Sciences Public Fund, L.P. reported a 6.90% stake in Kalvista Pharmaceuticals, Inc., 3,466,521 shares, with active intent on Nov 1, 2025. Filed Nov 4, 2025 (Schedule 13D/A).

Stake
6.90%
Shares
3,466,521
Intent
Active
What changed
Stake changed
Filed together
11 holders

The filing in full

HolderStakeShares
Frazier Life Sciences Public Fund, L.P.6.90%3,466,521
FHMLSP, L.P.6.90%3,466,521
FHMLSP, L.L.C.6.90%3,466,521
Frazier Life Sciences X, L.P.2.30%1,160,700
FHMLS X, L.P.2.30%1,160,700
FHMLS X, L.L.C.2.30%1,160,700
Frazier Life Sciences XI, L.P.0.80%394,847
FHMLS XI, L.P.0.80%394,847
FHMLS XI, L.L.C.0.80%394,847
James N. Topper2.30%1,160,700
Patrick J. Heron2.30%1,160,700

Source

View original at SEC

Related